Nestrolan (Trazodone Hydrochloride)

Trazodone, the active ingredient in Nestrolan, is a serotonin antagonist and reuptake inhibitor (SARI) presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients. The medication works by modulating serotonergic pathways to improve mood and alleviate depressive symptoms.

GNH USA supplies Nestrolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets.

Trazodone is indicated for conditions related to mood regulation and depressive disorders.

- Major depressive disorder: alleviates depressive symptoms and improves overall mood. - Depressive episodes in bipolar disorder (adjunct): may be used when other agents are insufficient. - Depression with associated insomnia (adjunct): can help improve sleep quality while treating depressive symptoms.

Trazodone may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a parched sensation. - Dizziness: light‑headedness or loss of balance. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Priapism: prolonged, painful erection requiring urgent care. - Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening. - Serotonin syndrome: potentially fatal condition with agitation, hyperthermia, and muscle rigidity. - Severe hypotension: marked drop in blood pressure causing faintness. - Hepatic injury: signs of liver dysfunction such as jaundice. - Suicidal thoughts: emergence or worsening of suicidal ideation.

Before initiating therapy with Nestrolan, several safety considerations should be reviewed.

- Cardiac assessment: evaluate history of heart disease or arrhythmias. - Suicide risk monitoring: watch for emergence of suicidal thoughts, especially early in treatment. - Hepatic function: use caution in patients with liver impairment. - Discontinuation: avoid abrupt cessation to reduce withdrawal symptoms. - Drug interaction review: assess concomitant medications for serotonergic activity. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Trazodone can interact with a variety of medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Other serotonergic agents (e.g., SSRIs, SNRIs): increased serotonin toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise trazodone plasma levels.

Moderate Interactions (Monitor Closely): - Central nervous system depressants (e.g., benzodiazepines): enhanced sedation. - Antihypertensive drugs: additive blood‑pressure lowering effect. - Alcohol: may increase drowsiness and dizziness.